
About Orbit Pharma Laboratories LLP
Data last updated:
Orbit Pharma Laboratories LLP was a limited liability partnership (LLP) based in Kalol, Gujarat, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 October 2020.
The LLP was registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAU-4237.
The LLP had a total obligation of contribution of ₹10 Lakh. It was led by designated partners including Naranbhai Parshotambhai Kikani and Rima Kunal Kikani.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office was at Block No. 155/1 4 159 Chhatral Kadi Road Village Dhanot, Kalol, Gujarat, India – 382729.
The LLP has about 35 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹11.71 Cr and satisfied charges of ₹17.5 Lakh on record. Court records list 10 cases involving the LLP, including 10 filed against it.
The last known website on record is orbitpharm.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBlock No. 155/1 4 159 Chhatral Kadi Road Village Dhanot, Kalol, Gujarat, India – 382729
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Orbit Pharma Laboratories LLP FY 2024 filings available
Financial Statement Summary of Orbit Pharma Laboratories LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Orbit Pharma Laboratories LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Orbit Pharma Laboratories are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Orbit Pharma Laboratories LLP
Orbit Pharma Laboratories has 4 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naranbhai Parshotambhai Kikani Also directs: Orbit Pharma Laboratories Limited | Designated Partner | 26 Oct 2020 | 5 Years 11 Months | As last reported |
| Rima Kunal Kikani Also directs: Orbit Pharma Laboratories Limited, Khwaish Organics LLP | Partner | 10 Apr 2024 | 2 Years 6 Months | As last reported |
| Kunal Naranbhai Kikani Also directs: Orbit Pharma Laboratories Limited, Khwaish Organics LLP | Designated Partner | 01 Sep 2022 | 4 Years 1 Months | As last reported |
| Smitaben Naranbhai Kikani Also directs: Orbit Pharma Laboratories Limited | Partner | 26 Oct 2020 | 5 Years 11 Months | As last reported |
Charges & Borrowings of Orbit Pharma Laboratories LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2022 | Bank of Maharashtra | ₹2.11 Cr | Open |
| 26 Oct 2020 | Bank of Maharashtra | ₹60 Lakh | Open |
| 26 Oct 2020 | Bank of Maharashtra | ₹4.5 Cr | Open |
| 26 Oct 2020 | Bank of Maharashtra | ₹3 Cr | Open |
| 26 Oct 2020 | Bank of Maharashtra | ₹1.5 Cr | Open |
Total charge records: 6 View all charges
Legal Cases of Orbit Pharma Laboratories LLP
Orbit Pharma Laboratories LLP has 10 court cases on record: 10 filed against it. All cases are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed against the company by Paarichem Resources LLP | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Sudersun Chemical Private Limited | Disposed |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Sudersun Chemical Private Limited | Disposed |
| District court, GANDHINAGAR, Gujarat | Commercial matter | Filed against the company by Radiant International Private Limited | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Umiya Enviro Project LLP | Disposed |
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Orbit Pharma Laboratories LLP
Employment history and EPFO contributions of people linked to Orbit Pharma Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Orbit Pharma Laboratories LLP
Orbit Pharma Laboratories LLP has 5 designated partner changes on record since 2020: 4 appointments and 1 cessation. The latest: Rima Kunal Kikani was appointed as Partner on 10 Apr 2024.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Orbit Pharma Laboratories LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Orbit Pharma Laboratories LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Orbit Pharma Laboratories LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Orbit Pharma Laboratories LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Orbit Pharma Laboratories LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orbit Pharma Laboratories LLP
Orbit Pharma Laboratories has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.
Orbit Pharma Laboratories was a limited liability partnership based in Kalol, Gujarat, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 26 October 2020 and is registered under LLPIN AAU-4237. For the latest details, refer to the successor company.
The LLPIN (Limited Liability Partnership Identification Number) of Orbit Pharma Laboratories is AAU-4237. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Orbit Pharma Laboratories had 4 designated partners:
- Naranbhai Parshotambhai Kikani - Designated Partner
- Rima Kunal Kikani - Partner
- Kunal Naranbhai Kikani - Designated Partner
- Smitaben Naranbhai Kikani - Partner
Orbit Pharma Laboratories was incorporated on 26 October 2020. It is registered with the Registrar of Companies, Ahmedabad.
Orbit Pharma Laboratories can be reached through the website orbitpharm.com. Its registered office is in Kalol, Gujarat, India.
The registered office of Orbit Pharma Laboratories is at Block No. 1551 4 159 Chhatral Kadi Road Village Dhanot, Kalol, Gujarat, India – 382729.
The total obligation of contribution is ₹10 Lakh.
Orbit Pharma Laboratories operated in the pharma industry, in the drug formulation and development segment.
Orbit Pharma Laboratories has 10 court cases on record: 10 filed against it.